US Oncology Investor Relations Salary | Comparably
US Oncology operates a network of integrated community-based oncology practices that provides cancer care services in the United States. read more
EMPLOYEE
PARTICIPANTS
80
TOTAL
RATINGS
550

US Oncology Investor Relations Salary

The average US Oncology Investor Relations earns an estimated $59,007 annually. US Oncology's Investor Relations compensation is $22,923 less than the US average for a Investor Relations.

The Communications Department at US Oncology earns $3,305 more on average than the Enterprise Risk Department.

Last updated 7 months ago.

$35k
$47k
$63k
$70k
$109k
$139k
$168k
$59,007
Average Compensation
$59,007
avg. base

Investor Relations Salaries at US Oncology

* estimated salary

Compensation at US Oncology by Department

The Communications Department averages $3,305 more than the Enterprise Risk Department.

Communications
$189,704 Avg. total comp.
Enterprise Risk
$186,399 Avg. total comp.
-$3k
Product
$167,047 Avg. total comp.
-$23k

Investor Relations Compensation by Gender (All Companies)

The average female Investor Relations at companies similar size to US Oncology reported making $155,000, while the average male Investor Relations at similar sized companies reported making $50,000.

How Investor Relations at US Oncology Rate Their Compensation

The majority of Investor Relations at US Oncology believe they're compensated fairly. 50% of Investor Relations at US Oncology say they receive annual bonuses, and the majority (60%) are satisfied with their benefits. See more compensation ratings at US Oncology

×
Rate your company